
Nearly 1 in 5 people in the United States over the age of 12 haven’t gotten at least one shot. Some may be reluctant to take a vaccine they believe has only been tested for a few months, but that couldn’t be further from the truth, says Michelle Carlin, an assistant professor of forensic chemistry at Rutgers University–Camden.

The biotechnology company Oxolife S.L. (Spain), the Energy Balance, Puberty and Reproductive Health research group of the University of Cordoba (Spain) and the Human Growth and Reproductive Development research group at Rutgers University, have initiated a triple international collaboration to further investigate the direct mechanisms of the drug OXO-001, designed to improve embryo implantation and to treat infertility associated with Polycystic Ovary Syndrome (PCOS).

A novel medical device that works as an absorbable implant for meniscal reconstruction, invented by researchers at Rutgers, received the 2021 Thomas Edison Patent Award in the Biotechnology category. The tissue-engineered implant treats meniscal tears to lessen or even entirely rid the need for a total knee replacement surgery.

Jeffrey L. Carson, MD, whose research has profoundly reshaped transfusion medicine by establishing evidence-based national standards, saving vital blood and enhancing care for even the most critical of patients, is being honored by the American College of Physicians (ACP) with the John Phillips Memorial Award for Outstanding Work in Clinical Medicine for his career-long journey to improve health outcomes for patients.

President Jonathan Holloway and Prabhas Moghe, executive vice president for academic affairs, recently announced the recipients of the Universitywide Faculty Awards for 2020-21. The awards recognize the excellence of educators at Rutgers in every stage of their careers for the work they do guiding the intellectual development of students, for their exceptional research accomplishments and for the difference they make in the community.